Pharmaceuticals Studies suggest promise for psilocybin in treating symptoms of depression Last updated: August 22, 2024 7:13 pm By bexib 0 Min Read Share SHARE Recent research has demonstrated that high doses of psilocybin are more effective at reducing depression symptoms than placebo or escitalopram in patients with major depressive disorder. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article Will the IRA kill new drugs? Such fears are likely overblown, the study says. Next Article New Drug Trial Investigating Treatment for Patients with Bronchiectasis Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News From Porsche to Purpose: A CMO’s Journey Retail & E-commerce Upskilling: An interview with Steph Piper Manufacturing Young Kiwis toast change: hazardous drinking falls by 13% in five years Hospitality & Tourism Clearview FCU saves 6,000 labor hours through RPA Banking